Watch Ticker

Keros Therapeutics, Inc. Common Stock

Go to Keros Therapeutics, Inc. Common Stock Website

$14.62

0.30 (2.09%)

Live

Previous Close

$14.32

Day Range

$14.225 - $14.75

Previous Day Range

$14.2509 - $14.5

Market Cap

$581.6 million USD

Day Vol.

223754

Previous Day Vol.

261048

Currency

USD

Primary Exchange

Nasdaq

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet m...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Keros Therapeutics, Inc. - Leading Independent Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote “FOR” All of Keros’ Director Nominees

Keros Therapeutics announced that leading independent proxy advisory firm Glass Lewis recommended that Keros stockholders vote 'FOR' all three of the company's director nominees for the upcoming Annual Meeting. Keros stated that the board is best equipped to oversee the strategic review process and execute on the ultimate outcome.

Related tickers: KROS.

Read Full Article

Delveinsight - Blood Cancer Treatment Market Sees Accelerated Growth Across the 7MM Amid Rising Incidence and Breakthroughs | DelveInsight

The blood cancer market is experiencing robust growth, driven by rising incidence rates and advancements in targeted therapies and immuno-oncology. Increasing adoption of CAR-T cell therapies, monoclonal antibodies, and personalized medicine is transforming treatment outcomes.

Related tickers: ABBV, SLS, MRK, AAPG, JNJ, ADCT, BMY, CELGr, REGN, RHHBY, ACLX, KROS, SYRS, BGNE, ONC.

Read Full Article

Trending Tickers

Please sign in to view